Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Todd Neale

September 26, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News HRS 2023

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

Michael O'Riordan

June 05, 2023

News Daily News

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Michael O'Riordan

April 05, 2023

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Industry News

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

April 26, 2017

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

News Daily News

Transcatheter Pulmonary Valve Implantation Feasible in Smaller Children

March 05, 2014

News Daily News

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

January 01, 2014

Advertisement

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

Similar Outcomes in Men and Women After Transcatheter Tricuspid Interventions

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

UH Case Medical Center first in Ohio to implant new ventricular assist device

Transcatheter Pulmonary Valve Implantation Feasible in Smaller Children

Ultrasound-Accelerated Thrombolysis More Effective Than Heparin Alone for Intermediate PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content